| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.701 | 27.178 | 28.010 | 25.987 | 26.664 | 19.402 | 12.962 | 10.507 | 10.812 | 10.800 |
| Total Income - EUR | 24.219 | 27.990 | 30.447 | 29.518 | 33.021 | 27.521 | 16.168 | 10.507 | 10.812 | 11.999 |
| Total Expenses - EUR | 22.863 | 26.455 | 30.309 | 27.709 | 33.417 | 26.029 | 15.491 | 2.083 | 1.903 | 8.460 |
| Gross Profit/Loss - EUR | 1.356 | 1.536 | 138 | 1.809 | -396 | 1.491 | 678 | 8.423 | 8.909 | 3.539 |
| Net Profit/Loss - EUR | 674 | 1.264 | -142 | 1.549 | -663 | 1.332 | 479 | 8.115 | 7.836 | 2.984 |
| Employees | 0 | 4 | 5 | 5 | 0 | 4 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Terapeutica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.789 | 18.815 | 18.497 | 18.158 | 17.806 | 17.468 | 6.175 | 5.654 | 5.099 | 4.610 |
| Current Assets | 2.899 | 521 | 723 | 2.245 | 1.151 | 2.323 | 972 | 193 | 2.197 | 4.536 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.652 | 168 | 196 | 1.965 | 29 | 930 | 8 | 0 | 320 | 3.019 |
| Cash | 247 | 353 | 526 | 280 | 1.122 | 1.393 | 964 | 193 | 1.877 | 1.517 |
| Shareholders Funds | 399 | 1.659 | 1.489 | 3.011 | 2.290 | 3.296 | -8.746 | -659 | 7.180 | 7.643 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.289 | 17.678 | 17.731 | 17.392 | 16.667 | 16.496 | 15.894 | 6.506 | 117 | 1.504 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Terapeutica Srl